A non-profit scientific association founded in 1968, whose main objective is to promote and disseminate the study of Hepatology in Latin America, through training and the exchange of scientific knowledge and experiences, to reduce current gaps in the world.
Booths: 408, 424
AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.
AcariaHealth™, a leading comprehensive specialty pharmacy company, provides various healthcare solutions through our unique brand of services. We offer specialized Hepatitis C care management services and are dedicated to continuing to enhance the patient care offering, collaboration with providers and the capture of relevant data to measure patient outcomes.
Accredo is a full-service specialty pharmacy dedicated to the treatment of rare and complex conditions. Our comprehensive therapy management programs engage specialty-trained pharmacists, nurses, reimbursement specialists, and patient care representatives who provide enhanced support services to patients, their families, and healthcare professionals.
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion’s metabolic franchise includes highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare disorders, Kanuma™ (sebelipase alfa) to treat patients with lysosomal acid lipase deficiency (LAL-D).
The Alpha-1 Foundation is a not-for-profit organization that is dedicated to providing the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha-1 Antitrypsin Deficiency.
Founded in 1976, the American Liver Foundation (ALF) is the nation’s leading nonprofit health organization for people living with liver disease. We are a nationwide network of staff and volunteers that provides awareness, outreach, education and patient support services to educate the public about liver health and to improve the lives of individuals and their families affected by liver disease.
Amsety has developed the first nutrition bar to support liver health. Designed by a team of liver health specialists, scientists and food engineers, our bars contain no refined sugars, are sodium free, gluten free, dairy free, vegetarian and kosher. Amsety Bars can only be purchased on our website at www.amsety.com
At Apothecary By Design, we are reimagining pharmacy care. We offer a full range of specialty services, including authorization and appeals advocacy, copay assistance, and expert clinical support. Our team of certified specialty pharmacists and patient care coordinators works 24/7 to achieve the best possible outcomes for patients and partners.
APASL is one of the leading associations based on investigation and treatment of liver diseases in the world. APASL’s main objectives are to promote the latest scientific advancement and education of hepatology science, exchange of information and the development of consensus, and encourage the practice of medicine in liver diseases.
Our staff at Aureus Health Services, helps patients and physicians gain access to medications, work through insurance coverage, out-of-pocket challenges, and educate patients on their prescription drugs. We supply drug distribution and management services for chronic conditions including HCV, HIV, Crohn’s Disease, Rheumatoid Arthritis, Osteo-Arthritis, Osteoporosis, Multiple Sclerosis, etc.
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power.
BioPredictive offers diagnostic and prognostic blood tests for liver diseases. Over a million tests performed worldwide. BioPredictive’s diagnosis and prognosis tests (FiboTest-ActiTest, FibroMax, HCV-GenoFibroTest including IL28b ) are available on line at www.biopredictive.com FibroTest App (free) including ElastoFibroTest and DAAFibroTest available on iPhone and Android.
Blue Faery: The Adrienne Wilson Liver Cancer Association is devoted to fighting primary liver cancer. Founded in Burbank, California, with a satellite location in Birmingham, Alabama, Blue Faery’s mission is to prevent, treat and cure primary liver cancer through research, education and advocacy. For more information, visit www.bluefaery.org.
Contact: (508) 683-4166
Boston Scientific is dedicated to transforming patient lives by developing diagnostic and therapeutic devices that support less invasive, more efficient procedures for a variety of GI conditions. Through innovation and partnership, we are advancing important clinical research, supporting education programs and helping healthcare institutions deliver high quality healthcare while managing costs.
BriovaRx™ is a truly patient-centric specialty pharmacy, dedicated to making a meaningful impact on every patient’s well-being. We offer comprehensive, personalized specialty pharmacy care, including drug reimbursement verification and advocacy, confidential overnight delivery, patient education and emergency support for patients, competitive pricing and access to many limited distribution medications.
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews
CRH Medical is dedicated to bringing innovative solutions to gastroenterologists. The CRH O’Regan System® is both safe and effective for the treatment of hemorrhoids -- and it has now been adopted by over 2,300 gastroenterologists nationwide. With the introduction of CRH Anesthesia Management, we are also now working to address anesthesia service needs at GI ASCs across the country.
CTI Clinical Trial and Consulting Services is an innovative, international drug and device development organization that delivers a full spectrum of clinical trial and consulting services from bench to commercialization with a focus on immunology and a passion for helping lifechanging therapies succeed in chronically and critically ill patient populations.
Our commitment to helping patients and their physicians manage complex drug therapies by delivering individualized care with expertise, compassion and dedication has made us one of the leading specialty pharmacies in the country. To learn more or to enroll patients, call 1-800-238-7828.
Zydus Cadila is an innovative, global pharmaceutical company that discovers, manufactures and markets a broad range of healthcare therapies. The group employs over 19000 people worldwide. The group has a strong research pipeline of NCEs, biologics and vaccines and aims to become a global research based pharmaceutical company by 2020.
The Cholangiocarcinoma Foundation is a global network of people dedicated to supporting, educating and advocating for those affected by cholangiocarcinoma. Our mission to find a cure drives our efforts to facilitate and accelerate research into prevention, early detection and treatments that prolong and improve the quality of our patient's lives.
City Drugs is a leading pharmacy for providing the dispensing and support services for medications which treat complex and chronic diseases. We are licensed in multiple states throughout the country. Our compassionate clinical staff provide a patientcentric focus and superior medication support services across major therapeutic categories. www.citydrugs.com
The CHBG is a nonprofit, international clinical research group. In issue 7, 2016 of The Cochrane Library, we published 303 peerreviewed protocols and 181 systematic reviews. A CHBG Register on randomised and controlled clinical trials is maintained in the CENTRAL database. Cochrane reviews are not industry funded.
The focus of the CLA is to provide support and education to those experiencing liver illnesses, their caregivers, and health professionals. The vision also includes educating the community about liver wellness and advocating to legislators to ensure that issues surrounding liver disease, screenings, education and research funding is recognized and supported.
ContextMedia:Health is the leading provider of digital education solutions at the point of care. ContextMedia:Health’s comprehensive suite of products, including the Waiting Room TV, Exam Room Tablet, Patient Wifi and Digital Exam Room Wallboard, drives a more robust dialogue between physicians and patients to improve patient health outcomes.
What’s pending at Diapharma? Discuss what’s new in CK18 biomarkers for NASH and AH research at Booth 608. CK18, an abundant and critical protein in the liver, plays a role in cell death, a hallmark of liver disease. Explore M30/M65 ELISAs for measuring hepatocyte apoptosis and cell death noninvasively.
Diplomat is the nation’s largest independent specialty pharmacy. We work with the entire health care ecosystem to connect patients who have chronic and rare conditions to medication, information and funding. Our hightouch and uniquely personal approach is backed by exceptional results in patient satisfaction, prescriber satisfaction, adherence rates and more.
The Duke Clinical Research Institute (DCRI), the largest academic research organization globally, conducts groundbreaking multinational clinical trials, manages major national patient registries, and performs landmark outcomes research. The DCRI combines the faculty expertise of one of the most prestigious university medical centers with fullservice operational capabilities.
Dynavax Technologies Corporation is a clinicalstage biopharmaceutical company with multiple product candidates in development for the prevention of infectious disease, the treatment of autoimmune and inflammatory diseases, and the treatment of cancer. We develop cutting edge immunotherapies based on TollLike Receptor (TLR) biology and its ability to modulate the immune system.
Contact: (857) 2701713
Echosens is the world’s leading provider of noninvasive, point of care medical devices dedicated to the liver. Our FibroScan® devices are the first to be FDA cleared as an aid for managing patients with liver disease. Echosens also offers the FibroView™ connectivity solution as well as the FibroMeter™ blood test.
EntrustRx believes in a high touch model of care. We understand some therapies can be intimidating so we dedicate ourselves to helping patients every step of the way making the process as smooth as possible. We provide all specialty pharmacy needs from patient assistance with copays to nurse training.
Since 1966, EASL has continued to grow into a major European Association with international influence dedicated to liver research. It has 4,000+ members and its International Liver Congress™ unites over 10,000 liver experts. EASL supports clinical trials and research for the benefit of patients worldwide. Visit www.easl.eu.
ExeGi Pharma distributes Visbiome, a high potency probiotic medical food intended for the dietary management of dysbiosis associated with irritable bowel syndrome, ulcerative colitis, and pouchitis. Visbiome offers a very high potency of bacteria ranging from 112.5 billion bacteria900 billion bacteria, depending on the product. Visbiome is available in capsules, packets, and prescriptionstrength packets.
Gastroenterology & Endoscopy News, a monthly newspaper, provides smart, objective and comprehensive clinical news reporting from international, national and regional gastroenterology meetings. It also features indepth original articles, educational reviews, CME monographs and monthly commentary from celebrated gastroenterologists.
Gastroenterology & Hepatology is a monthly, independent peerreviewed journal that is mailed to all US gastroenterologists and hepatologists (16,700+). Content is directed by strong input of experts in the field. G&H contains thought leaderdriven review articles, clinical case studies with expert commentary, and advances columns featuring engaging interviews with experts on current issues in IBD, IBS, GERD, Hepatitis and Endoscopy.
GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. Elafibranor, its lead compound, is currently evaluated in a large pivotal international Phase 3 study.
Booths: 301, 205
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet need. The company's mission is to transform and simplify care for people with lifethreatening illnesses around the word. Headquartered in Foster City, California, Gilead has operations in North and South America, Europe and AsiaPacific.
The Gore Medical Products Division has provided creative solutions to medical problems for four decades. Over 40 million Gore Medical Devices have been implanted worldwide. Products include vascular grafts, endovascular and interventional devices, surgical materials, and sutures for use in vascular, cardiac and general surgery. For more information, visit www.goremedical.com.
HealthHCV, and initiative of HealthHIV, seeks to advance education and training on HCV across all sectors of healthcare by providing key advocacy messages and presenting HCV data and information in compelling visuals. From primary care and allied health professionals to consumers, HealthHCV impacts the HCV epidemic through tailored, educational programs.
The HealthWell Foundation is an independent nonprofit dedicated to reducing financial barriers to care for underinsured Americans with chronic and lifealtering medical conditions. HealthWell offers a financial lifeline to adults and children who desperately need critical medical treatments but can't afford them by assisting with their costsharing obligations. Learn more: www.HealthWellFoundation.org.
Hong Kong Humanity & Health Medical Group, composed with H&H Research Center; H&H Medical Center (GI & Liver Center, Digestive Endoscopy Centre, Hepatitis C Diagnosis & Treatment Center cooperated with Beijing 302 Hospital of PLA); Explicit Global Medical Group Limited (Medical Diagnostic and Health Assessment Center, Medical Laboratory Center). Visit us at www.hnhmgl.com.
Contact: (888) 4159964
FDA approved Tens medical device
Intercept is a biopharmaceutical company focused on developing and commercializing novel therapeutics to treat underserved chronic liver diseases such as primary biliary cirrhosis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. Our product candidates have the potential to treat liver diseases for which there currently are limited therapeutic options.
LabCorp is one of the nation's premier laboratories for treating infectious disease, including Hepatitis C Virus. Through an extensive test menu, staff expertise, and integrated testing from our Center's of Excellence (Monogram BioSciences, The Center for Molecular Biology and Pathology and ViroMed Laboratories), LabCorp offers a singlesource solution for the treatment of acute and chronic infections.
The Lancet Gastroenterology & Hepatology covers all aspects of gastroenterology and hepatology. Following in The Lancet tradition, each monthly issue features original clinical research, expert reviews, news, and provocative comment and opinion to provide a clear, independent perspective of the clinical advances and practicechanging research shaping your field.
Median Technologies, a leading medical imaging solutions and services provider for image interpretation will introduce its Imaging Biomarker Phenotyping System (IBIOPSY) for the non-invasive assessment of hepatic steatosis and fibrosis using CT texture analysis, specifically targeted at diagnosis and follow-up of NASH. IBIOPSY is made possible using patented high-throughput image analysis methods and cloud computing technologies.
Today's Merck is working to help the world be well. Through our medicines, vaccines, biologic therapies, and consumer and animal products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. For more information visit www.merck.com.
Contact: (301) 4584240
The National Death Index is a computerized index of death record information from the state vital statistics offices. Working with the states, the NDI was established as a resource to aid epidemiologists and other health and medical investigators with mortality ascertainment. The NDI is restricted to medical and health research.
The NIAAA exhibit features publications appropriate for the public, research findings for professional and for policymakers, and research grant opportunities available for biomedical and social science researchers. Please visit us at www.NIAAA.NIH.gov.
We are Novartis and we are reimagining medicine. Our mission is to discover new ways to improve and extend people’s lives. We use sciencebased innovation to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
OWL Metabolomics is a biotech firm that identifies, validates, patents and commercializes novel diagnostic and prognostic tools for specific liver diseases. OWL has unique expertise in NASH/NAFLD diagnostics & noninvasive liquid biomarker development, metabolomic services, metabolite profiling, biomarker discovery via signature analysis, personalized medicine, and companion diagnostics.
OraSure Technologies manufactures oral fluid devices and other technologies designed to detect or diagnose critical medical conditions. Its innovative products include rapid tests for HIV and HCV antibodies, influenza antigens, testing solutions for detecting drugs of abuse, and oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications.
Our mission is to unite people diagnosed with Primary Biliary Cholangitis (formerly known as Primary Biliary Cirrhosis), which is a progressive chronic liver disease. Our organization helps PBC patients, their care givers, friends and families cope with PBC and improve the quality of their lives through education and support
Our mission is to provide education and support to PSC patients, families and caregivers and to raise funds to research causes, treatments and potential cures for primary sclerosing cholangitis. We value physician participation in our annual patient conferences, PSC patient registry and our PSC research grants program.
Perspectum Diagnostics’ proprietary technology and flagship product, LiverMultiScan, is a customisable software analysis tool that uses innovative multiparametric MRI for whole liver assessment. It quickly and accurately measures liver fat as well as correlates for iron and fibrosis/inflammation. Perspectum’s research platform, LiverMultiScan Discover, is currently supporting research and clinical trials.
Philips is a leading health technology company focused on improving people’s health and enabling better outcomes. Philips ultrasound systems offer a range of helpful tools in noninvasively assessing liver disease including 2D imaging across patient types, vascular visualization with color Doppler and liver stiffness assessment with shear wave elastography.
PhoenixBio produces the PXBMouse® Model the world's most widely used humanized liver chimeric mouse model for predicting an accurate human response in DMPK/Toxicology, Hepatitis B & C, Liver Diseases, Oligonucleotides, and GeneEditing research fields. We provide professionally tailored study services and deliver accurate preclinical translational results mimicking human responses.
Plexision develops and markets cellbased tests for personalized disease management and drug development for the Immunocompromized host. The company's first product, Pleximmune, is FDA approved to predict rejection in children with liver or intestine transplantation. Plexision's products and services are offered from its CLIAapproved, GLP and GMPcompliant reference laboratory.
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world’s largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. We serve half of the physicians and hospitals in the United States. QuestDiagnostics.com.
Recordati Rare Diseases is a biopharmaceutical company committed to providing therapies to people with rare diseases. We strive to reduce the impact of devastating diseases and restore health. We work sidebyside with rare disease communities to increase awareness, improve diagnosis, and ensure access to effective treatments. Please visit www.recordatirarediseases.com.
Resoundant technology allows MRI scanner manufacturers to offer Magnetic Resonance Elastrography (MRE), a noninvasive, fast and reliable diagnostic test for assessing liver fibrosis. The technology was developed at the Mayo Clinic and is now available to patients around the world.
Retrophin is a biopharmaceutical company focused on the discovery and development of drugs for the treatment of catastrophic diseases that are debilitating and often lifethreatening, and for which there are currently limited patient options.
For over 20 years, Salix Pharmaceuticals, a whollyowned subsidiary of Valeant Pharmaceuticals International, Inc. has been committed to providing solutions for the management of many chronic and debilitating conditions. Salix currently markets products to U.S. healthcare providers in the areas of gastroenterology, hepatology, internal medicine, primary care, infectious disease, and allergy/immunology.
Samsara Sciences, Inc. specializes in the provision of primary human liver cells for use in human biology and disease research. Our products include hepatocytes, stellate cells, endothelial cells, and Kupffer cells, isolated from healthy or diseased donors with confirmed NAFLD or fibrosis. In addition to cryopreserved cells, we offer tissueoforigin paraffin blocks and snapfrozen tissues.
Sanyal Biotechnology is a contract research organization specializing in preclinical small animal model screening of drugs. We have developed a proprietary mouse model, the DIAMONDTM mouse, that develops NAFLD and NASH solely as a result of Western Diet.
Shire is the leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions.
SLACK Incorporated, delivering the best in health care information and education worldwide, invites you to booth #104. Pick up a free issue of HCV Next and Healio Gastroenterology. Sign up for the free news wire at Healio.com.
SuperSonic Imagine is an innovative ultrasound imaging company that has developed a revolutionary ultrasound system: the Aixplorer®. Aixplorer is the only system on the market with a real time ShearWave™ Elastography exam. The exam takes as little as 60 seconds and provides image guided quantification of liver tissue stiffness.
TLCRx is a privately held company and built to be a clinical pharmacy providing solutions for caregivers and patients undergoing highcost, complex drug treatment. Our programs blend a hightouch, caring patient experience with specialized clinical knowledge, personalized care programs, and administrative expertise.
University of Minnesota Health has been a pioneer in transplant medicine for over 50 years. Their physicians have led innovation, research and education for transplant providers worldwide. The Solid Organ Transplant Program transplants annually over 600 adult and pediatric patients collectively making us a market leader in transplant services.
Established in 1981, UPMC has performed more than 17,500 transplants, including liver, kidney, pancreas, small bowel, liver/small bowel, heart, heart/lung, doublelung, singlelung, and multipleorgan transplants. A leader in transplantation, UPMC is dedicated to advancing basic science and clinically applied research. Above all, we are committed to providing compassionate, comprehensive care.
Vital Therapies, Inc. is a biotherapeutic company developing a human hepatic cellbased system for the treatment of liver failure. The Company’s ELAD® System is an extracorporeal human allogeneic cellular liver treatment currently in Phase 3 clinical trials for acute alcoholic hepatitis. www.aahstudy.com
Wako Diagnostics offers biomarkers AFPL3 (lectinreactive alphafetoprotein) and DCP (desgammacarboxy prothrombin) to aid in the early detection of hepatocellular carcinoma (HCC) in atrisk patients, increasing the possibility of timely application of curative therapies and improved patient outcomes. Both blood tests are 510(k)cleared, CMS reimbursed, and available at major reference laboratories.
Wiley is a global provider of knowledge and knowledge-enabled services that improve outcomes in areas of research, professional practice, and education. Visit www.wiley.com for more information.
Wilson Therapeutics is a biopharmaceutical company that develops novel therapies for patients with rare diseases such as Wilson Disease. Wilson Therapeutics’ lead product, Decuprate®, is initially being developed as a novel treatment for Wilson Disease and is currently being evaluated in a Phase II clinical study.